Key result
Sodium restriction plus BQ123 reduces proteinuria by ~/min compared to habitual sodium intake.
Why the study?
Endothelin-A receptor antagonists are emerging treatments for proteinuric CKD, but whether dietary sodium intake influences their systemic and kidney therapeutic efficacy had not been investigated.
Does dietary sodium restriction enhance the systemic and kidney hemodynamic and antiproteinuric effects of acute selective endothelin-A receptor antagonism (BQ123) in adults with non-diabetic proteinuric chronic kidney disease?
RCT (n=12)
Double-blind
Random order crossover
Does dietary sodium restriction enhance the systemic and kidney hemodynamic and antiproteinuric effects of acute selective endothelin-A receptor antagonism (BQ123) in adults with non-diabetic proteinuric chronic kidney disease?
Dietary sodium restriction (~6.3 g salt/day) is required to unlock the acute antiproteinuric and glomerular hemodynamic benefits of endothelin-A receptor antagonism in patients with proteinuric CKD on RAAS inhibition.
Answers are grounded in this paper and cite their sources.
Sodium restriction is required for acute antiproteinuric and glomerular hemodynamic effects of ET-A antagonism; extends RAAS findings to this pathway in proteinuric CKD.
Introduction Endothelin-A receptor antagonists (ERAs) are emerging as an important treatment for proteinuric chronic kidney disease (CKD). As with renin-angiotensin-aldosterone system (RAAS) inhibition, dietary sodium intake may influence their therapeutic efficacy, but this has not been investigated. Here, we examined whether dietary sodium restriction enhances the systemic and kidney effects of acute selective endothelin-A (ETA) receptor antagonism in proteinuric CKD. Methods In a randomized, double-blind, placebo-controlled crossover study, 12 adults (mean age 46 years) with non-diabetic proteinuric CKD (mean eGFR 55 mL/min/1.73 m 2 ; median proteinuria 1.8 g/day) receiving maximally tolerated RAAS inhibition completed two 14-day dietary interventions (habitual dietary sodium intake [13.3 g salt/day] and dietary sodium restriction [6.3 g salt/day, approximating guideline-recommended levels]) in random order. During each dietary period, participants underwent two study visits and received intravenous infusion of either placebo or the selective ET A receptor antagonist, BQ123. Systemic hemodynamics, arterial stiffness, kidney hemodynamics and proteinuria were assessed following each intervention. Results BQ123 produced comparable reductions in systolic blood pressure (about 12-14 mmHg), systemic vascular resistance and arterial stiffness under both dietary conditions and increased kidney blood flow (about 320-335 mL/min) irrespective of dietary sodium intake. In contrast, significant reductions in glomerular filtration rate (peak placebo-adjusted reduction: about 5 mL/min/1.73 m 2 ), effective filtration fraction (peak reduction about 1.5%), and proteinuria (about 300 μg/min) were observed only during dietary sodium restriction and not during habitual sodium intake. Conclusions Dietary sodium restriction enhances the short-term kidney efficacy of selective endothelin-A receptor antagonism in proteinuric CKD while preserving its beneficial systemic hemodynamic effects. As ERAs become established therapies for proteinuric kidney disease, these findings suggest that adherence to dietary sodium restriction may maximize their kidney-protective benefits. Whether the acute changes demonstrated here translate into long-term kidney protection requires prospective evaluation.
No takes yet. Share an insight, caveat, or question.
Pugh et al. (2026) conducted an RCT in Non-diabetic proteinuric chronic kidney disease (n=12). BQ123 (selective ETA receptor antagonist) intravenous infusion plus dietary sodium restriction vs. Placebo infusion and habitual dietary sodium intake (13.3 g salt/day) was evaluated on Systemic hemodynamics, arterial stiffness, kidney hemodynamics, and proteinuria (MD -5 mL/min/1.73 m2 (GFR); -1.5% (filtration fraction); -300 μg/min (proteinuria)). Dietary sodium restriction combined with BQ123 reduced GFR by ~5 mL/min/1.73 m2, filtration fraction by ~1.5%, and proteinuria by ~/min, whereas habitual sodium intake did not.
Synapse has enriched 10 related papers. Consider them for comparative context: